RPG Life Sciences Limited (RPGLIFE.NS) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

+55.5%

₹3,958.73

vs ₹2,545.70 price

Levered DCF

₹1,846.15

After debt service

Piotroski score

3 / 9

Weak

Altman Z-score

—

Rating

C+

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	26.68×	20.37×	29.12×	17.13×	18×	16.01×	9.68×	39.59×
P/B	5.08×	7.03×	6.81×	3.77×	3.62×	2.96×	1.59×	2.67×
P/S	4.34×	5.71×	4.42×	2.28×	2.12×	1.67×	0.76×	1.32×
EV / EBITDA	16.66×	23.2×	18.57×	10.46×	9.65×	8.39×	5.25×	13.52×
Gross margin	41.3%	67.2%	68.0%	33.3%	65.6%	64.1%	65.4%	66.0%
Operating margin	17.8%	47.9%	19.0%	17.2%	16.2%	14.3%	11.6%	5.9%
Net margin	16.3%	28.0%	15.2%	13.3%	11.8%	10.4%	7.9%	3.3%
Current ratio	3.48×	3.88×	2.28×	2.57×	2.58×	2.21×	1.52×	1.25×
Debt / equity	0.03×	0×	0×	0×	0×	0.01×	0.07×	0.23×
Interest coverage	141.13×	505.29×	76.38×	76.06×	50.17×	30.57×	15.56×	3.95×
Dividend yield	1.3%	0.7%	0.8%	1.4%	1.3%	0.0%	4.5%	1.1%
Payout ratio	34.5%	14.4%	22.6%	23.5%	23.1%	0.0%	44.0%	44.3%

Key metrics by fiscal year

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	19.0%	34.5%	23.4%	22.0%	20.1%	18.5%	16.4%	6.7%
Return on invested capital	14.7%	45.8%	21.4%	20.5%	18.8%	18.2%	17.6%	6.8%
Return on assets	14.5%	27.9%	17.1%	16.1%	14.9%	13.2%	10.9%	4.3%
Free cash flow yield	-0.0%	1.1%	1.0%	5.0%	4.4%	7.8%	14.0%	6.1%
Earnings yield	3.7%	4.9%	3.4%	5.8%	5.6%	6.2%	10.3%	2.5%
Enterprise value	₹29.4B	₹37B	₹25.3B	₹11.3B	₹8.7B	₹6B	₹2.9B	₹4.6B
Net debt / EBITDA	-0.74×	-0.18×	-0.14×	-0.23×	-0.62×	-0.53×	0.2×	1.05×
Cash conversion cycle (days)	84	72	61	59	119	88	73	101